492 related articles for article (PubMed ID: 12045168)
1. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study.
Homma S; Sacco RL; Di Tullio MR; Sciacca RR; Mohr JP;
Circulation; 2002 Jun; 105(22):2625-31. PubMed ID: 12045168
[TBL] [Abstract][Full Text] [Related]
2. Atrial anatomy in non-cardioembolic stroke patients: effect of medical therapy.
Homma S; Sacco RL; Di Tullio MR; Sciacca RR; Mohr JP
J Am Coll Cardiol; 2003 Sep; 42(6):1066-72. PubMed ID: 13678932
[TBL] [Abstract][Full Text] [Related]
3. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale.
Homma S; DiTullio MR; Sacco RL; Sciacca RR; Mohr JP;
Stroke; 2004 Sep; 35(9):2145-9. PubMed ID: 15232117
[TBL] [Abstract][Full Text] [Related]
4. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Messé SR; Silverman IE; Kizer JR; Homma S; Zahn C; Gronseth G; Kasner SE;
Neurology; 2004 Apr; 62(7):1042-50. PubMed ID: 15078999
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.
Saver JL; Carroll JD; Thaler DE; Smalling RW; MacDonald LA; Marks DS; Tirschwell DL;
N Engl J Med; 2017 Sep; 377(11):1022-1032. PubMed ID: 28902590
[TBL] [Abstract][Full Text] [Related]
6. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks.
Cujec B; Mainra R; Johnson DH
Can J Cardiol; 1999 Jan; 15(1):57-64. PubMed ID: 10024860
[TBL] [Abstract][Full Text] [Related]
7. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
[TBL] [Abstract][Full Text] [Related]
8. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
9. Patent foramen ovale in cryptogenic stroke: current understanding and management options.
Wu LA; Malouf JF; Dearani JA; Hagler DJ; Reeder GS; Petty GW; Khandheria BK
Arch Intern Med; 2004 May; 164(9):950-6. PubMed ID: 15136302
[TBL] [Abstract][Full Text] [Related]
10. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
Khan AR; Bin Abdulhak AA; Sheikh MA; Khan S; Erwin PJ; Tleyjeh I; Khuder S; Eltahawy EA
JACC Cardiovasc Interv; 2013 Dec; 6(12):1316-23. PubMed ID: 24139929
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
[TBL] [Abstract][Full Text] [Related]
12. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm.
Mas JL; Zuber M
Am Heart J; 1995 Nov; 130(5):1083-8. PubMed ID: 7484740
[TBL] [Abstract][Full Text] [Related]
13. [Cryptogenic stroke and patent foramen ovale].
Windecker S; Nedeltchev K; Wahl A; Meier B
Ther Umsch; 2003 Sep; 60(9):553-61. PubMed ID: 14579624
[TBL] [Abstract][Full Text] [Related]
14. Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale.
Turc G; Lee JY; Brochet E; Kim JS; Song JK; Mas JL;
J Am Coll Cardiol; 2020 May; 75(18):2312-2320. PubMed ID: 32381162
[TBL] [Abstract][Full Text] [Related]
15. Management of patients with stroke and a patent foramen ovale.
Rodriguez CJ; Homma S
Curr Cardiol Rep; 2004 Mar; 6(2):143-6. PubMed ID: 14759360
[TBL] [Abstract][Full Text] [Related]
16. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
Mas JL; Derumeaux G; Guillon B; Massardier E; Hosseini H; Mechtouff L; Arquizan C; Béjot Y; Vuillier F; Detante O; Guidoux C; Canaple S; Vaduva C; Dequatre-Ponchelle N; Sibon I; Garnier P; Ferrier A; Timsit S; Robinet-Borgomano E; Sablot D; Lacour JC; Zuber M; Favrole P; Pinel JF; Apoil M; Reiner P; Lefebvre C; Guérin P; Piot C; Rossi R; Dubois-Randé JL; Eicher JC; Meneveau N; Lusson JR; Bertrand B; Schleich JM; Godart F; Thambo JB; Leborgne L; Michel P; Pierard L; Turc G; Barthelet M; Charles-Nelson A; Weimar C; Moulin T; Juliard JM; Chatellier G;
N Engl J Med; 2017 Sep; 377(11):1011-1021. PubMed ID: 28902593
[TBL] [Abstract][Full Text] [Related]
17. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
Windecker S; Wahl A; Nedeltchev K; Arnold M; Schwerzmann M; Seiler C; Mattle HP; Meier B
J Am Coll Cardiol; 2004 Aug; 44(4):750-8. PubMed ID: 15312853
[TBL] [Abstract][Full Text] [Related]
18. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale.
Schuchlenz HW; Weihs W; Berghold A; Lechner A; Schmidt R
Int J Cardiol; 2005 May; 101(1):77-82. PubMed ID: 15860387
[TBL] [Abstract][Full Text] [Related]
19. Comparison of medical treatments in cryptogenic stroke patients with patent foramen ovale: A randomized clinical trial.
Shariat A; Yaghoubi E; Farazdaghi M; Aghasadeghi K; Borhani Haghighi A
J Res Med Sci; 2013 Feb; 18(2):94-8. PubMed ID: 23914208
[TBL] [Abstract][Full Text] [Related]
20. Effect of aspirin and warfarin therapy in stroke patients with valvular strands.
Homma S; Di Tullio MR; Sciacca RR; Sacco RL; Mohr JP;
Stroke; 2004 Jun; 35(6):1436-42. PubMed ID: 15073397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
